Antidiabetic Drugs Prescription Spatial Variability

Newer Antidiabetic Drugs

The current oral blood glucose lowering agents and dietary measures only partially correct the multiple metabolic defects in NIDDM with insulin resistance remaining relatively impervious to treatment Hypoglycaemia and secondary failure are common with presently available sulphonylureas and hence the need for newer blood glucose lowering drugs. In case of NIDDM, a successful new drug should corr...

Assessment of Prescription Pattern of Antidiabetic Drugs in the Outpatient Department of a Tertiary Care Hospital

Background: Glycemic control remains the major therapeutic objective for prevention of target organ damage and other complications arising from diabetes. Poor glycemic control in diabetes mellitus can be prevented by using rational use of oral hypoglycemic agents (OHA). Rational use of the drugs in populations can be effectively evaluated using drug utilization studies. Method: Necessary approv...

Evaluation of the community pharmacist’s behavior towards a prescription of antidiabetic and antiasthma drugs

OBJECTIVE The objective of this study is to assess the performance of community pharmacist towards antidiabetic and antiasthma prescriptions, and also to assess the lack of information provided by community pharmacists regarding patient counseling and missing data, using a simulated patient technique. METHODS A prescription including antidiabetic and antiasthma drugs was used by simulated pat...

Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities

Oral Antidiabetic Drugs for Cats

Diabetes mellitus (DM) is commonly diagnosed in cats. In humans, treatment regimens for non–insulin-dependent DM include various combinations of dietary modification, exercise, insulin administration, and one or more oral antidiabetic drugs, which have been extensively evaluated in humans but not in cats. Glucose toxicity is a phenomenon of chronic hyperglycemia and must be understood before in...